Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,431.19 13.51 0.09%
TOPIX 1,166.33 -0.22 -0.02%
HANG SENG 22,771.71 75.70 0.33%

Dr. Reddy's to Release Q1 FY14 Results on July 30, 2013

  Dr. Reddy's to Release Q1 FY14 Results on July 30, 2013

         Earnings call slated for July 30, 6.30 PM IST / 9.00 AM EDT*

Business Wire

HYDERABAD, India -- July 19, 2013

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First
Quarter ended June 30, 2013 on Tuesday, July 30, 2013 after the Board Meeting.
The results will be available on the Company’s website

Summary of Events
Event                    Date and Time (IST)        Medium
Release of financial     July 30th, after the       Email, Media, Company
results                  Board Meeting              website, Business Wire
Earnings Call            July 30th, 6.30 PM IST     Hosted by the Company
                         / 9:00 AM EDT              (Details below)
                         July 30th, 6.30 PM IST     URL available on Company’s
Webcast of Earnings      / 9.00 AM EDT through      website,
Call                     August 4th, 2013
Transcripts of the       Will be available on       URL available on Company’s
Earnings call            the Company’s website      website,

Earnings Call

Following the release, the management of the Company will host an earnings
call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number:                +91 22 6629 0356
Secondary Number:              +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all
                               6000 1221
                               Available in - Ahmedabad, Bangalore,
                               Bhubaneswar, Chandigarh, Chennai, Coimbatore,
                               Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore,
                               Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur,
                               Kolkata, Nagpur, Noida, Patna, Pune, Raipur,
Local Access Number:           Rajkot, Surat, Trivandrum, Vadodara, Vijayawada
                               Accessible from all major carriers except
                               3940 3977
                               Available in Ahmedabad, Bangalore, Chandigarh,
                               Chennai, Kochi/Cochin, Gurgaon (NCR),
                               Hyderabad, Kolkata, Lucknow, Pune
                               Accessible from all carriers.
                               USA: 1 866 746 2133
International Toll Free        UK: 0 808 101 1573
                               Singapore: 800 101 2045
                               Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As
participation in the call is limited, early registration is encouraged. The
operator will provide instructions on asking questions before and during the

Audio Webcast

The audio webcast of the earnings call will be available to all interested
parties at Please visit the web site at least fifteen
minutes ahead of the scheduled start time to register and to download and
install any necessary audio software. Participants in the webcast can listen
to the proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through August 4th, 2013. For play
back dial in phone No: 022 3065 1212 and ID: 375#.


The transcript of the earnings call will also be available on the Company's

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses – Pharmaceutical
Services and Active Ingredients, Global Generics and Proprietary Products –
Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular,
diabetology, oncology, pain management and anti-infective. Major markets
include India, USA, Russia-CIS and Europe apart from other select geographies
within Emerging Markets.

For more information, log on to:

*EDT- Eastern Daylight Saving Time


Investor Relations:
Dr. Reddy's Laboratories
Kedar Upadhye, +91 40 66834297
Saunak Savla, +91 40 49002135
Milan Kalawadia (USA), +1 9082034931
Sponsored Links
Sponsored Links